Lakefront Biotherapeutics | GLPG - Interest Income


Lakefront Biotherapeutics reported EUR13.56M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
argenx SE USD 44M 874K Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Biogen USD 37.9M 700K Mar/2026
Genmab DKK 25M 8M Jun/2025
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Incyte USD 38.12M 4.43M Jun/2026
Merck EUR 36M 15M Mar/2026
Sanofi EUR 77M 17M Jun/2026
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026